ARFGAP1 and Parkinson disease: LRRK2(leucine-rich repeat kinase 2) activity, whose mutations are the most common causefor Parkinson’s Disease, inhibits ArfGAP1 GAP-activity and ArfGAP1 isable to stimulate LRRK2 activity47, 48.